4 CONCLUSION
The Majority of HIV patients with opportunistic
infection in mean age 36 years, male, Bataknese, have
more than 9 years attainment of education, have
employment. They come to clinic in less CD4,
anemia, less BMI, in stadium four, receiving
antiretroviral therapy not routine. More than half with
Tuberculosis infection and still alive
ACKNOWLEDGEMENTS
This study supported by DRPM Kemenristek Dikti
fund (Basic Research Scheme) in 2018 based on
contract number 124/UN5.2.3.1/PPM/ KP-
DRPM/2018
REFERENCES
WHO, 2017. Treat all: Policy adoption and implementation
status in countries. Fact sheet. Link:
http://www.who.int/hiv/pub/progressreports/en/
UNAIDS, 2017. UNAIDS DATA 2017. Available in link:
http://www.unaids.org/en/resources/documents/2017/2
017_data_book
Kemenkes RI, 2017. Statistik kasus HIV/AIDS di Indonesia
dilapor s/d Desember 2016, Jakarta
KPAN, 2010. Laporan Komisi Penanggulangan AIDS
Nasional tahun 2010. Kementrian Koordinator Bidang
Kesejahteraan Rakyat Republik Indonesia
Lubis, R., Bulgiba, A., Kamarulzaman, A., Hairi, N. N.,
Dahlui, M., & Peramalah, D. (2013). Predictors of
death in Malaysian HIV-infected patients on anti-
retroviral therapy. Preventive medicine, 57, S54-S56.
Rodwell L, Richard FWB, Moore M, Strathdee SA, Raich
A, et al, 2010. HIV Tuberculosis Coinfection in
Southern California: Evaluating Disparities in Disease
Burden. Am J Public Health (Suppl 1): S178–S185
Hermans SM, Kiragga A, Schaefer P, Kambugu A,
Hoepelman AIM, et al, 2010. Incident Tuberculosis
during Antiretroviral Therapy Contributes to
Suboptimal Immune reconstitution in a Large Urban
HIV Clinic in Sub-Saharan Africa. PLoS ONE 5(5)
WHO, 2011. World Health Organization Guidelines for
intensified tuberculosis casefinding and isoniazid
preventive therapy for people living with HIV in
resourceconstrained settings. Geneva.
Moore D, Liechty C, Ekwarua P, Werea W, Mwimaa G, et
al, 2017. Prevalence, incidence and mortality associated
with Tuberculosis in HIVinfected patients initiating
antiretroviral therapy in rural Uganda. AIDS 21 (6)
Lienhardt C, Fielding K, Sillah JS, Bah B, Gustafson P, et
al, 2015. Investigation of the risk factors for
tuberculosis: a case-control study in three countries in
West Africa. Int J of Epidemiol 34: 914–923
Bonnet MMB, Loretexu LPP, Francis FVV, Barbara BOO,
Daniel DOO’B, et al.2016. Tuberculosis after HAART
initiation in HIV-positive patients from five countries
with a high tuberculosis burden. AIDS 20(9):1275–
1279
Safira, N., Lubis, R., & Fahdhy, M. (2018). Factors
Affecting Adherence to Antiretroviral Therapy. KnE
Life Sciences, 4(4), 60–70. doi:
HTTPS://DOI.ORG/10.18502/KLS.V4I4.2264